Back

The nocebo effect in statin therapy: clinical implications for adherence and cardiovascular outcomes

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Implementing novel lipid‑lowering therapies Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marine Sargsyan

Yerevan State Medical University after M. Heratsi, Yerevan (Armenia)

4 More presentations in this session

Presentation thumbnail
Comparative effectiveness of lipid-lowering regimens for achieving ESC LDL-cholesterol targets in acute coronary syndrome: a real-world cohort analysis
Doctor A. Romiou (Marousi, GR)
Abstract Slides Video
Presentation thumbnail
Variability in lipoprotein(a) measurements in ODYSSEY OUTCOMES: is one-and-done testing sufficient?
Professor P. Steg (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Nationwide implementation of PCSK9--targeted therapies after myocardial infarction and ischemic stroke: structural barriers and disparities in a universal healthcare system
Assistant Professor P. Sedova (Brno, CZ)
Abstract Slides Video
Presentation thumbnail
Atorvastatin for prevention of chemotherapy-induced cardiotoxicity: a 5-year propensity-matched cohort study of 800 patients
Doctor R. Rascon Sabido (Veracruz, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Implementing novel lipid‑lowering therapies

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Practical approach to statin intolerance
28 August 2026
thumbnail
Congress Presentation
Beta-blockers in patients with uncomplicated arterial hypertension: data from the Campania Salute Network Registry
29 August 2026
thumbnail
Congress Presentation
Treatment patterns and adherence to lipid-lowering drugs during 8 years of follow-up after a cardiovascular event
25 August 2023
thumbnail
Congress Presentation
Effects of colchicine on platelet reactivity among stable post-myocardial infarction patients: a double-blind randomized controlled trial.
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources